Skip to main content
. 2023 May 15;15(5):3442–3450.

Table 4.

Univariate analysis of cognitive function

Variable Cognitive dysfunction group (n = 41) Non-disorder group (n = 73) x2/t value P value
Age 8.305 0.004
    ≥ 60 years (n = 63) 30 33
    < 60 years (n = 51) 11 40
Sex 2.638 0.104
    Male (n = 67) 20 47
    Female (n = 47) 21 26
BMI 0.588 0.443
    ≥ 25 kg/m2 (n = 42) 17 25
    < 25 kg/m2 (n = 72) 24 48
Time from onset to admission 4.494 0.034
    ≥ 6 h (n = 49) 23 26
    < 6 h (n = 65) 18 47
Medical history
    Diabetes (n = 51) 27 24 11.554 0.001
    Hyperlipidemia (n = 38) 23 15 14.932 0.001
Lesion at critical sites 11.012 0.001
    Critical site (n = 45) 27 18
    Non-critical site (n = 69) 23 55
NIHSS score before treatment 23.58±3.77 24.97±3.47 1.937 0.055
MRS score before treatment 3.97±1.04 3.97±0.93 0.015 0.987

Note: Body Mass Index (BMI), National Institutes of Health Stroke Scale (NIHSS) score, modified Rankin Scale (mRS) score, frontal lobe, temporal lobe, base, thalamus as critical sites, parietal lobe, occipital lobe, brainstem, cerebellum as non-critical sites.